XML 31 R19.htm IDEA: XBRL DOCUMENT v3.20.2
STOCK-BASED COMPENSATION (Tables)
6 Months Ended
Jun. 30, 2020
Share-based Payment Arrangement [Abstract]  
SCHEDULE OF STOCK BASED COMPENSATION

The following table summarizes stock option-based compensation for the three and six months ended June 30, 2020 and 2019:

 

SCHEDULE OF STOCK BASED COMPENSATION 

   For the three
months ended
June 30,
   For the three
months ended
June 30,
   For the six
months ended
June 30,
   For the six
months ended
June 30,
 
   2020   2019   2020   2019 
Research and development  $871,000   $1,009,000   $1,615,000   $2,041,000 
General and administrative   707,000    669,000    1,219,000    1,740,000 
Stock option-based compensation expense included in operating expense   1,578,000    1,678,000    2,834,000    3,781,000 
                     
Total stock option-based compensation expense   1,578,000    1,678,000    2,834,000    3,781,000 
Tax benefit   -    -    -    - 
Stock option-based compensation expense, net of tax  $1,578,000   $1,678,000   $2,834,000   $3,781,000 

  

SCHEDULE OF WEIGHTED-AVERAGE ASSUMPTIONS TO ESTIMATE THE FAIR VALUE OF THE OPTIONS GRANTED

We used the following weighted-average assumptions to estimate the fair value of the options granted for the periods indicated:

 

 

   For the three
months ended
June 30,
   For the three
months ended
June 30,
   For the six
months ended
June 30,
   For the six
months ended
June 30,
 
   2020   2019   2020   2019 
Expected volatility   111%   108%   111%   108%
Expected term   6.25 years    5 years    6.25 years    5 years 
Risk-free interest rate   0.23%   2.21%   0.30%   2.24%
Expected dividend yield   0%   0%   0%   0%

SCHEDULE OF OPTIONS ACTIVITY

 The following table summarizes the options granted for the periods indicated:

 

 

   For the three
months ended
June 30,
   For the three
months ended
June 30,
   For the six
months ended
June 30,
   For the six
months ended
June 30,
 
   2020   2019   2020   2019 
Options granted   1,897,119    1,183,890    3,073,046    1,384,890 
Weighted-average:                    
Exercise price  $2.83   $6.86   $2.30   $6.84 
Grant date fair value  $2.36   $5.39   $1.92   $5.37 
SCHEDULE OF RESTRICTED COMMON STOCK SHARE-BASED COMPENSATION

 

   For the three
months ended
June 30,
   For the three
months ended
June 30,
   For the six
months ended
June 30,
   For the six
months ended
June 30,
 
   2020   2019   2020   2019 
Research and development  $147,000   $-   $472,000   $- 
General and administrative   40,000    78,000    179,000    250,000 
Restricted stock-based compensation expense included in operating expense   187,000    78,000    651,000    250,000 
                     
Total restricted stock-based compensation expense   187,000    78,000    651,000    250,000 
Tax benefit   -    -    -    - 
Restricted stock-based compensation expense, net of tax  $187,000   $78,000   $651,000   $250,000